Dupont Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-20,637
Closed -$577K 1238
2019
Q2
$577K Sell
20,637
-18,456
-47% -$513K 0.01% 714
2019
Q1
$1.21M Hold
39,093
0.03% 495
2018
Q4
$924K Buy
39,093
+6,390
+20% +$175K 0.02% 556
2018
Q3
$1.27M Hold
32,703
0.03% 509
2018
Q2
$1.09M Hold
32,703
0.03% 530
2018
Q1
$1.19M Buy
32,703
+19,384
+146% +$671K 0.03% 472
2017
Q4
$424K Sell
13,319
-14,978
-53% -$513K 0.01% 693
2017
Q3
$1.06M Hold
28,297
0.02% 508
2017
Q2
$883K Buy
+28,297
New +$817K 0.02% 549

Other funds holding LMAT

Dupont Capital Management's LMAT Position: Q3 2019 in Review

Dupont Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2019, closing a stake of 20,637 shares — an estimated $577K sold.

Dupont Capital Management first reported a position in LMAT in Q2 2017 and held it in 9 quarters. The position peaked at $1.27M in Q3 2018. 145 funds tracked by Wall St. Rank hold LMAT as of Q3 2019.

  • Dupont Capital Management reported no remaining LeMaitre Vascular position as of Q3 2019 after selling out during the quarter.
  • Dupont Capital Management sold 20,637 LeMaitre Vascular shares in Q3 2019, an estimated $577K.
  • Dupont Capital Management first reported a position in LeMaitre Vascular in Q2 2017 and held it in 9 quarters.
  • Dupont Capital Management's LeMaitre Vascular position peaked at $1.27M in Q3 2018.
  • 145 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2019.

Based on Dupont Capital Management's 13F filing for Q3 2019, filed 28 Oct 2019.